Atomoxetine PBPK-PD Clinical Study
Condition(s):ADHDLast Updated:August 8, 2023Completed
Hide Studies Not Open or Pending
Condition(s):ADHDLast Updated:August 8, 2023Completed
Condition(s):ADHD NOSLast Updated:August 21, 2019Completed
Condition(s):Attention Deficit Hyperactivity Disorder; Cannabis AbuseLast Updated:August 24, 2010Terminated
Condition(s):Attention Deficit Hyperactivity DisorderLast Updated:June 13, 2007Completed
Condition(s):Parkinson’s Disease; Cognitive ImpairmentLast Updated:August 23, 2018Completed
Condition(s):Autistic Disorder; Attention Deficit Disorder With HyperactivityLast Updated:May 11, 2010Completed
Condition(s):Attention Deficit Hyperactivity Disorder; DyslexiaLast Updated:November 4, 2022Completed
Condition(s):ADHDLast Updated:November 6, 2007Completed
Condition(s):Attention-Deficit/Hyperactivity Disorder; Comorbid DyslexiaLast Updated:January 26, 2007Completed
Condition(s):Attention Deficit Hyperactivity Disorder; Oppositional Defiant DisorderLast Updated:January 18, 2010Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.